-
Something wrong with this record ?
Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial
PFA. Mulders, L. Martínez-Piñeiro, A. Heidenreich, M. Babjuk, M. Colombel, R. Colombo, P. Radziszewski, I. Korneyev, C. Surcel, P. Yakovlev, JA. Witjes, C. Caris, R. Schipper, WPJ. Witjes, MAGNOLIA Study Group of the EAU Research Foundation,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Chemotherapy, Adjuvant MeSH
- Antigens, Neoplasm therapeutic use MeSH
- Cystectomy MeSH
- Double-Blind Method MeSH
- Immunotherapy * MeSH
- Neoplasm Invasiveness MeSH
- Clinical Trials, Phase II as Topic MeSH
- Humans MeSH
- Neoplasm Proteins therapeutic use MeSH
- Urinary Bladder Neoplasms drug therapy pathology surgery MeSH
- Early Termination of Clinical Trials MeSH
- Randomized Controlled Trials as Topic MeSH
- Recombinant Proteins therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The MAGNOLIA study, investigating the concept of perioperative immunotherapy in muscle- invasive bladder cancer, was prematurely terminated. The lessons learned that should be considered before initiating and conducting future clinical trials in this field are highlighted.
EAU Research Foundation Arnhem The Netherlands
Hôpital Edouard Herriot Lyon France
Hospital Motol Charles University Prague Czech Republic
Kiev Municipal Oncology Hospital Kiev Ukraine
Medical University Warsaw Warsaw Poland
Radboud University Medical Centre Nijmegen The Netherlands
Saint Petersburg State Pavlov Medical University St Petersburg Russia
Universitätsklinikum Köln Köln Germany
University of Medicine and Pharmacy Carol Davila Bucharest Romania
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028829
- 003
- CZ-PrNML
- 005
- 20210114155213.0
- 007
- ta
- 008
- 210105s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.euf.2018.02.005 $2 doi
- 035 __
- $a (PubMed)29477797
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Mulders, Peter F A $u Radboud University Medical Centre, Nijmegen, The Netherlands.
- 245 10
- $a Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial / $c PFA. Mulders, L. Martínez-Piñeiro, A. Heidenreich, M. Babjuk, M. Colombel, R. Colombo, P. Radziszewski, I. Korneyev, C. Surcel, P. Yakovlev, JA. Witjes, C. Caris, R. Schipper, WPJ. Witjes, MAGNOLIA Study Group of the EAU Research Foundation,
- 520 9_
- $a The MAGNOLIA study, investigating the concept of perioperative immunotherapy in muscle- invasive bladder cancer, was prematurely terminated. The lessons learned that should be considered before initiating and conducting future clinical trials in this field are highlighted.
- 650 _2
- $a antigeny nádorové $x terapeutické užití $7 D000951
- 650 _2
- $a adjuvantní chemoterapie $7 D017024
- 650 _2
- $a klinické zkoušky, fáze II jako téma $7 D017322
- 650 _2
- $a cystektomie $7 D015653
- 650 _2
- $a dvojitá slepá metoda $7 D004311
- 650 _2
- $a předčasné ukončení klinických zkoušek $7 D057239
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a imunoterapie $7 D007167
- 650 _2
- $a invazivní růst nádoru $7 D009361
- 650 _2
- $a nádorové proteiny $x terapeutické užití $7 D009363
- 650 _2
- $a randomizované kontrolované studie jako téma $7 D016032
- 650 _2
- $a rekombinantní proteiny $x terapeutické užití $7 D011994
- 650 _2
- $a nádory močového měchýře $x farmakoterapie $x patologie $x chirurgie $7 D001749
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Martínez-Piñeiro, Luis $u Hospital La Paz, Madrid, Spain.
- 700 1_
- $a Heidenreich, Axel $u Universitätsklinikum Köln, Köln, Germany.
- 700 1_
- $a Babjuk, Marko $u Hospital Motol, Charles University, Prague, Czech Republic.
- 700 1_
- $a Colombel, Marc $u Hôpital Edouard Herriot, Lyon, France.
- 700 1_
- $a Colombo, Renzo $u University Vita Salute San Raffaele Hospital, Milan, Italy.
- 700 1_
- $a Radziszewski, Piotr $u Medical University Warsaw, Warsaw, Poland.
- 700 1_
- $a Korneyev, Igor $u Saint Petersburg State Pavlov Medical University, St. Petersburg, Russia.
- 700 1_
- $a Surcel, Cristian $u University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
- 700 1_
- $a Yakovlev, Pavel $u Kiev Municipal Oncology Hospital, Kiev, Ukraine.
- 700 1_
- $a Witjes, J Alfred $u Radboud University Medical Centre, Nijmegen, The Netherlands.
- 700 1_
- $a Caris, Christien $u EAU Research Foundation, Arnhem, The Netherlands.
- 700 1_
- $a Schipper, Raymond $u EAU Research Foundation, Arnhem, The Netherlands.
- 700 1_
- $a Witjes, Wim P J $u EAU Research Foundation, Arnhem, The Netherlands. Electronic address: w.witjes@curatrial.com.
- 710 2_
- $a MAGNOLIA Study Group of the EAU Research Foundation
- 773 0_
- $w MED00193513 $t European urology focus $x 2405-4569 $g Roč. 5, č. 5 (2019), s. 849-852
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29477797 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114155212 $b ABA008
- 999 __
- $a ok $b bmc $g 1609164 $s 1120009
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 5 $c 5 $d 849-852 $e 20180221 $i 2405-4569 $m European urology focus $n Eur Urol Focus $x MED00193513
- LZP __
- $a Pubmed-20210105